OBJECTIVE. We review the role of brain FDG PET in the diagnosis of Alzheimer disease,
frontotemporal dementia, dementia with Lewy bodies, and vascular dementia. Characteristic …

There is increasing use of neuroimaging modalities, including PET, for diagnosing
dementia. For example, FDG-PET demonstrates hypometabolic regions in the posterior …

Objectives The aim of this article was to review the current role of brain PET in the diagnosis
of Alzheimer dementia. The characteristic patterns of glucose metabolism on brain FDG-PET …

Positron emission tomography (PET) imaging with F-18 fluorodeoxyglucose (FDG) can be
used as a downstream marker of neuronal injury, a hallmark of neurodegenerative …

The purpose of this article is to present a selective and concise summary of
fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG …

The diagnosis of dementia syndromes can be challenging for clinicians, particularly in the
early stages of disease. Patients with higher education levels may experience a marked …

PET imaging with [F-18] FDG has been used extensively for research and clinical
applications in dementia. In the brain,[F-18] FDG accumulates around synapses and …

Distinguishing Alzheimer's disease (AD) and frontotemporal dementia (FTD) currently relies
on a clinical history and examination, but positron emission tomography with [18F] …

Background: Few studies have compared the accuracy of [18F] fluorodeoxyglucose (FDG)
PET to the accuracy of clinical and pathologic diagnosis in dementia patients. Methods …

The purpose of this study was to confirm with pathologic verification 2 beliefs related to
Alzheimer's disease (AD):(a) the long-standing impression that bilateral temporo-parietal …